U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07168473) titled 'Study to Evaluate the Efficacy and Safety of DW1807 in Perennial Allergic Rhinitis Patients With Asthma' on Sept. 04.
Brief Summary: This study aims to compare the efficacy and safety of DW1807 and DW1807-R2 in patients with perennial allergic rhinitis and comorbid asthma. The primary objective is to demonstrate the superiority of DW1807 over DW1807-R2 in improving the reflective total nasal symptom score (rTNSS) after 4 weeks of treatment.
Study Start Date: Sept. 09, 2024
Study Type: INTERVENTIONAL
Condition:
Perennial Allergic Rhinitis Accompanied by Asthma
Intervention:
DRUG: Experimental
1. DW1807 Once daily with water r...